Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stacy Lawrence

Showing results (31-40 of 66) with videos related to

Pageof 7
Sort By:
Nature Biotechnology|May 8, 2007
VC funding hits high in Q1Stacy Lawrence
Nature Biotechnology|May 10, 2017
Biotech's wellspring-a survey of the health of the private sector in 2016Stacy Lawrence
Nature Biotechnology|August 10, 2007
IPOs break $1 billion in Q2Stacy Lawrence
Nature Biotechnology|January 13, 2006
Tech transfer revs upStacy Lawrence
Nature Biotechnology|July 2, 2004
State of the biotech sectorStacy Lawrence
Nature Biotechnology|August 3, 2004
Biotech holds its own in Q2Stacy Lawrence
Nature Biotechnology|December 8, 2004
IPOs: the narrow window closes?Stacy Lawrence
Nature Biotechnology|April 9, 2005
Trends in the biotech literatureStacy Lawrence
Nature Biotechnology|November 23, 2005
Looking at US versus European exit opportunitiesStacy Lawrence
Nature Biotechnology|December 8, 2005
Biotech drug market steadily expandsStacy Lawrence
Pageof 7

Showing results (31-40 of 66) with videos related to

Sort By:
Pageof 7
Nature Biotechnology|May 8, 2007
VC funding hits high in Q1Stacy Lawrence
Nature Biotechnology|May 10, 2017
Biotech's wellspring-a survey of the health of the private sector in 2016Stacy Lawrence
Nature Biotechnology|August 10, 2007
IPOs break $1 billion in Q2Stacy Lawrence
Nature Biotechnology|January 13, 2006
Tech transfer revs upStacy Lawrence
Nature Biotechnology|July 2, 2004
State of the biotech sectorStacy Lawrence
Nature Biotechnology|August 3, 2004
Biotech holds its own in Q2Stacy Lawrence
Nature Biotechnology|December 8, 2004
IPOs: the narrow window closes?Stacy Lawrence
Nature Biotechnology|April 9, 2005
Trends in the biotech literatureStacy Lawrence
Nature Biotechnology|November 23, 2005
Looking at US versus European exit opportunitiesStacy Lawrence
Nature Biotechnology|December 8, 2005
Biotech drug market steadily expandsStacy Lawrence
Pageof 7